drugset / Trial / NCT00793559

Terlipressin Administration in Septic Shock Refractory to Catecholamines

NCT00793559

Phase 2 Unknown 30 enrolled Assaf-Harofeh Medical Center
RandomizedParallel-groupOpen-labelSupportive care

Summary

terlipressin is given to refractory septic shock patients who do not respond to noradrenalin in Israel and Europe. It is given by bolus injection. we attempt to investigate weather it is better to give it by continuous drip and avoid abrupt changes in BP and heart function

Timeline

Start
2008-11
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Terlipressin Peptide 1 mg